Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1975 1
1978 1
1990 4
1992 2
1993 2
1994 4
1995 5
1996 3
1998 1
2001 2
2002 1
2003 1
2004 4
2005 5
2006 12
2007 7
2008 17
2009 29
2010 16
2011 20
2012 20
2013 14
2014 17
2015 34
2016 37
2017 19
2018 31
2019 27
2020 27
2021 48
2022 45
2023 48
2024 54
2025 43

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

520 results

Results by year

Filters applied: . Clear all
Page 1
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer.
Makker V, Colombo N, Casado Herráez A, Santin AD, Colomba E, Miller DS, Fujiwara K, Pignata S, Baron-Hay S, Ray-Coquard I, Shapira-Frommer R, Ushijima K, Sakata J, Yonemori K, Kim YM, Guerra EM, Sanli UA, McCormack MM, Smith AD, Keefe S, Bird S, Dutta L, Orlowski RJ, Lorusso D; Study 309–KEYNOTE-775 Investigators. Makker V, et al. N Engl J Med. 2022 Feb 3;386(5):437-448. doi: 10.1056/NEJMoa2108330. Epub 2022 Jan 19. N Engl J Med. 2022. PMID: 35045221 Free PMC article. Clinical Trial.
A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45).
Monk BJ, Parkinson C, Lim MC, O'Malley DM, Oaknin A, Wilson MK, Coleman RL, Lorusso D, Bessette P, Ghamande S, Christopoulou A, Provencher D, Prendergast E, Demirkiran F, Mikheeva O, Yeku O, Chudecka-Glaz A, Schenker M, Littell RD, Safra T, Chou HH, Morgan MA, Drochýtek V, Barlin JN, Van Gorp T, Ueland F, Lindahl G, Anderson C, Collins DC, Moore K, Marme F, Westin SN, McNeish IA, Shih D, Lin KK, Goble S, Hume S, Fujiwara K, Kristeleit RS. Monk BJ, et al. Among authors: lim mc. J Clin Oncol. 2022 Dec 1;40(34):3952-3964. doi: 10.1200/JCO.22.01003. Epub 2022 Jun 6. J Clin Oncol. 2022. PMID: 35658487 Free PMC article. Clinical Trial.
Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis.
En Li Cho E, Ang CZ, Quek J, Fu CE, Lim LKE, Heng ZEQ, Tan DJH, Lim WH, Yong JN, Zeng R, Chee D, Nah B, Lesmana CRA, Bwa AH, Win KM, Faulkner C, Aboona MB, Lim MC, Syn N, Kulkarni AV, Suzuki H, Takahashi H, Tamaki N, Wijarnpreecha K, Huang DQ, Muthiah M, Ng CH, Loomba R. En Li Cho E, et al. Among authors: lim mc. Gut. 2023 Nov;72(11):2138-2148. doi: 10.1136/gutjnl-2023-330110. Epub 2023 Jul 25. Gut. 2023. PMID: 37491159
Optic Disc Drusen.
Chandra K, Lim MC, Liu YA. Chandra K, et al. Among authors: lim mc. Ophthalmology. 2022 Dec;129(12):1420. doi: 10.1016/j.ophtha.2022.03.008. Epub 2022 Jun 27. Ophthalmology. 2022. PMID: 35773065 No abstract available.
Proteogenomic characterization of molecular and cellular targets for treatment-resistant subtypes in locally advanced cervical cancers.
Hyeon DY, Nam D, Shin HJ, Jeong J, Jung E, Cho SY, Shin DH, Ku JL, Baek HJ, Yoo CW, Hong EK, Lim MC, Lee SJ, Bae YK, Kim JK, Bae J, Choi W, Kim SJ, Back S, Kang C, Madar IH, Kim H, Kim S, Kim DK, Kang J, Park GW, Park KS, Shin Y, Kim SS, Jung K, Hwang D, Lee SW, Kim JY. Hyeon DY, et al. Among authors: lim mc. Mol Cancer. 2025 Mar 14;24(1):77. doi: 10.1186/s12943-025-02256-3. Mol Cancer. 2025. PMID: 40087745 Free PMC article.
Comparative efficacy of pharmacologic therapies for MASH in reducing liver fat content: Systematic review and network meta-analysis.
Koh B, Xiao J, Ng CH, Law M, Gunalan SZ, Danpanichkul P, Ramadoss V, Sim BKL, Tan EY, Teo CB, Nah B, Teng M, Wijarnpreecha K, Seko Y, Lim MC, Takahashi H, Nakajima A, Noureddin M, Muthiah M, Huang DQ, Loomba R. Koh B, et al. Among authors: lim mc. Hepatology. 2024 Jul 19:10.1097/HEP.0000000000001028. doi: 10.1097/HEP.0000000000001028. Online ahead of print. Hepatology. 2024. PMID: 39028914
NF-kappaB-inducing kinase in cancer.
Maubach G, Feige MH, Lim MCC, Naumann M. Maubach G, et al. Among authors: lim mcc. Biochim Biophys Acta Rev Cancer. 2019 Jan;1871(1):40-49. doi: 10.1016/j.bbcan.2018.10.002. Epub 2018 Nov 9. Biochim Biophys Acta Rev Cancer. 2019. PMID: 30419317 Review.
GATA4 downregulation enhances CCL20-mediated immunosuppression in hepatocellular carcinoma.
Nasir NJM, Chuah S, Shuen T, Prawira A, Ba R, Lim MC, Chua J, Nguyen PHD, Lim CJ, Wasser M, Hazirah SN, Lim TKH, Leow WQ, Loh TJ, Wan WK, Pang YH, Soon G, Cheow PC, Kam JH, Iyer S, Kow A, Dan YY, Bonney GK, Chung A, Goh BKP, Chow PKH, Albani S, Zhai W, Ouyang JF, Toh HC, Chew V. Nasir NJM, et al. Among authors: lim mc. Hepatol Commun. 2024 Aug 19;8(9):e0508. doi: 10.1097/HC9.0000000000000508. eCollection 2024 Sep 1. Hepatol Commun. 2024. PMID: 39167427 Free PMC article.
520 results